Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingSep 9, 2026Clindamycin Injection USP in 5% DextroseCGMP DeviationsBaxter Healthcare Corporation · D-0817-2026Class IIOngoingSep 9, 2026Clindamycin Phosphate in 0.9% Sodium Chloride InjectionCGMP DeviationsBaxter Healthcare Corporation · D-0816-2026Class IIOngoingSep 9, 2026Clindamycin Injection USP in 5% DextroseCGMP DeviationsBaxter Healthcare Corporation · D-0815-2026Class IIOngoingSep 9, 2026NexteroneCGMP DeviationsBaxter Healthcare Corporation · D-0814-2026Class IIOngoingSep 9, 2026CARDENE IVCGMP DeviationsBaxter Healthcare Corporation · D-0813-2026Class IIOngoingSep 9, 2026Pantoprazole Sodium in 0.9% Sodium Chloride InjectionCGMP DeviationsBaxter Healthcare Corporation · D-0812-2026Class IIOngoingSep 9, 2026VasopressinCGMP DeviationsBaxter Healthcare Corporation · D-0811-2026Class IIOngoingSep 9, 2026Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride InjectionCGMP DeviationsBaxter Healthcare Corporation · D-0810-2026Class IIOngoingSep 9, 2026Famotidine Injection in Sodium Chloride InjectionCGMP DeviationsBaxter Healthcare Corporation · D-0809-2026Class IIOngoingSep 9, 2026Clindamycin Injection USP in 5% DextroseCGMP DeviationsBaxter Healthcare Corporation · D-0808-2026Class IIOngoingSep 9, 2026DaptomycinCGMP DeviationsBaxter Healthcare Corporation · D-0807-2026Class IIOngoingSep 9, 2026MYXREDLINCGMP DeviationsBaxter Healthcare Corporation · D-0806-2026Class IIOngoingSep 9, 2026Vancomycin InjectionCGMP DeviationsBaxter Healthcare Corporation · D-0805-2026Class IOngoingSep 2, 2026Lactated Ringer's Injection USPPresence of Particulate matter.B Braun Medical Inc · D-0832-2026Class IIOngoingSep 2, 2026Ramipril Capsules USPFailed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).Hikma Pharmaceuticals USA INC. · D-0831-2026Class IOngoingSep 2, 2026Tyenne (tocilizumab-aazg) InjectionPresence of particulate matter:An internal investigation at the firm found the product to contain glass particles.Fresenius Kabi USA, LLC · D-0827-2026Class IIOngoingSep 2, 2026Paxil CRFailed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteriaApotex Corp. · D-0804-2026Class IIOngoingSep 2, 2026Acthar GelPresence of particulate matter: glass and stopper pieceMallinckrodt Hospital Products Inc. · D-0803-2026Class IIOngoingSep 2, 2026Zicam, Cold RemedyCGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testingChurch & Dwight Co., Inc. · D-0790-2026Class IIOngoingSep 2, 2026Clobetasol Propionate Cream USPFailed content uniformity specifications.Lupin Pharmaceuticals Inc. · D-0789-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0786-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0785-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0784-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0783-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0782-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0781-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0780-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0779-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0778-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0777-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0776-2026Class IIOngoingSep 2, 2026Levothyroxine Sodium TabletsSubpotent DrugAccord Healthcare, Inc. · D-0775-2026Class IIOngoingAug 26, 2026niCARdipine Hydrochloride InjectionPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehydeAmerican Regent, Inc. · D-0802-2026Class IIOngoingAug 26, 2026TralementPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehydeAmerican Regent, Inc. · D-0801-2026Class IOngoingAug 26, 2026Papaverine HCl InjectionPresence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehydeAmerican Regent, Inc. · D-0800-2026Class IIOngoingAug 26, 2026MultrysPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehydeAmerican Regent, Inc. · D-0799-2026Class IIOngoingAug 26, 2026Selenious Acid InjectionPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehydeAmerican Regent, Inc. · D-0798-2026Class IIOngoingAug 26, 2026ACETYLCYSTEINE SOLUTIONPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehydeAmerican Regent, Inc. · D-0797-2026Class IIOngoingAug 26, 2026ACETYLCYSTEINE SOLUTIONPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehydeAmerican Regent, Inc. · D-0796-2026Class IIOngoingAug 26, 2026Atropine Sulfate injectionPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehydeAmerican Regent, Inc. · D-0795-2026